Now showing items 1-5 of 5
A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings : the miniPIERS (pre-eclampsia integrated estimate of risk) multi-country prospective cohort study
Background: Pre-eclampsia/eclampsia are leading causes of maternal mortality and morbidity, particularly in low- and middle- income countries (LMICs). We developed the miniPIERS risk prediction model to provide a simple, ...
Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term
(John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration, 2017)
Background: Hypertensive disorders in pregnancy are significant contributors to maternal and perinatal morbidity and mortality. These disorders include well‐controlled chronic hypertension, gestational hypertension ...
Inter-pregnancy interval and risk of recurrent pre-eclampsia : systematic review and meta-analysis
(BioMed Central, 2016-07-18)
Background: Women with a history of pre-eclampsia have a higher risk of developing pre-eclampsia in subsequent pregnancies. However, the role of the inter-pregnancy interval on this association is unclear. Objective: To ...
Ketanserin and hydralazine in hypertension in pregnancy : a randomised double-blind trial
(Health & Medical Publishing Group, 1995)
Objectives. To compare ketanserin with hydralazine in the treatment of hypertension in late pregnancy. Study design. Randomised control trial. Ten milligrams ketanserin were compared with 5 mg hydralazine, both given ...
Maternal and perinatal adverse outcomes in women with pre-eclampsia cared for at facility-level in South Africa : a prospective cohort study
(Edinburgh University Global Health Society, 2018)
Background: Hypertensive disorders of pregnancy contribute to 14% of all maternal deaths, the majority of which occur in low- and middle-income countries. The aim of the study was to describe the maternal and perinatal clinical ...